Outsourcing

Patrick Lavery is an Editor for the MJH Life Sciences brands 

. Previously at MJH, he filled the same role for 

Articles

The critical APIs that this funding will contribute to are used in the treatment of asthma, diabetes, and anxiety disorders.

APIIC Receives $14M Award for Development, Production of Three APIs

Videos

Bob Hughes (Research Fellow, Grace) and Brian Graves (Global Business Manager, Fine Chemicals, Grace) explain how Grace's experience as a CDMO can help customers from the lab to full-scale production. 

Grace: Your API CDMO Partner of Choice

This collaboration aims to support and accelerate clinical development of advanced and novel technologies.

Aurigene to Provide Cell Therapy Discovery Services to Edity to Support Clinical Development

Bill Humphries (CEO, Alcami) dives into an overview of Alcami's capabilities and how they value their client's innovations. 

Alcami: Beyond Expectations

Jason Hansell is Junior Applications Technologist at Colorcon Inc. (PA, USA).

Shahrzad Missaghi, PhD, is senior manager—Product Development at Colorcon.

A new generation of interactive formulation development platforms can leave trial and error in the formulation process in the past.

The New Digital Era for Formulation Development

The collaboration partner for Willow is focused on more sustainable methods to manufacture intermediates and APIs at reduced cost and less waste, in addition to looking for Willow’s expertise in developing and scaling key ingredients. 

Willow Biosciences Announces Collaboration with Biopharma Company 

The deal is worth up to $36 million with an initial upfront consideration of $14 million, with an additional $22 million in contingent value rights (CVRs) that is payable upon achieving certain milestones.

LEO Pharma to Acquire Timber Pharmaceuticals

Detection of nitrosamines in several commercial drugs has resulted in manufacturing batch recalls followed by a review of the APIs’ synthesis processes by MAHs. 

Contract Manufacturing, Drug Substance, API